SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-08-000500
Filing Date
2008-04-21
Accepted
2008-04-21 12:19:11
Documents
5
Period of Report
2008-04-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 16604
2 GENESENSE TECHNOLOGIES INC. AND ZOR PHARMACEUTICALS, LLC EXCLUSIVE LICENSE AGREE ex991.htm EX-99.1 707096
3 INDEPENDENT CONTRACTOR SERVICES AGREEMENT ex992.htm EX-99.2 66075
4 ZOR PHARMACEUTICALS, LLC LIMITED LIABILITY COMPANY AGREEMENT ex993.htm EX-99.3 426338
5 EUROPE europe.jpg GRAPHIC 417725
  Complete submission text file 0001279569-08-000500.txt   1793414
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 08766127
SIC: 2836 Biological Products, (No Diagnostic Substances)